Pharmacy Times
MAY 31, 2025
IVIG treatment significantly boosts platelet counts in pregnant people with thrombocytopenia, revealing key predictors for effective response and optimizing clinical decisions.
pharmaphorum
MAY 31, 2025
Here, Liz Beatty co-founder and chief strategy officer of Inato speaks to the beginnings of a new era in drug development brought on by key technological advances in AI.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmacy Times
MAY 31, 2025
GLP-1 receptor agonists, including semaglutide and tirzepatide, significantly reduce cardiometabolic risk factors such as dyslipidemia, type 2 diabetes, metabolic dysfunction-associated steatohepatitis, obstructive sleep apnea, chronic kidney disease, and cardiovascular events, with evidence suggesting that some of these benefits may occur independently of weight loss.
Drug Topics
MAY 31, 2025
Although there is no cure for MS, treatment focuses on recovery from attacks, reducing relapse, slowing disease progression, and managing multiple sclerosis symptoms.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Pharmacy Times
MAY 31, 2025
Gurjyot K. Doshi, MD, discusses key updates to medically integrated pharmacy standards, which reflect the evolving landscape of oral oncolytic therapy.
STAT
MAY 31, 2025
The Food and Drug Administration approved Moderna’s new Covid-19 vaccine late Friday , though it placed restrictions on its use that the company’s existing Covid shot, Spikevax, does not currently face. The new vaccine, which will be marketed under the name mNexspike, will not immediately replace Spikevax. A statement from the company said both vaccines will be available on the market for the time being.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
STAT
MAY 31, 2025
CHICAGO — A treatment that combines two different types of cancer-fighting medicines — Gilead Sciences’ Trodelvy with Merck’s Keytruda — reduced the risk of tumor progression by more than one-third in women with an aggressive form of breast cancer. The results reported Saturday from the randomized Phase 3 study called ASCENT-04 could lead to a new treatment option for patients with newly diagnosed, metastatic, triple-negative breast cancer, experts said.
Pharmacy Times
MAY 31, 2025
At the 2025 National Lipid Association (NLA) Scientific Sessions, Marlys L. Koschinsky, PhD, FNLA, discusses the role of Lp(a) in cardiovascular risk and the emerging therapies designed to target and lower Lp(a) levels.
IDStewardship
MAY 31, 2025
In this article an infectious diseases and antimicrobial stewardship pharmacist with 25+ years of experience in the pharmacy profession discusses five inconvenient truths to know about infectious diseases. Authored By: Timothy P. Gauthier, Pharm.D., BCPS, BCIDP with an introduction by ChatGPT AI-Generated Summary: This article outlines five fundamental truths about infectious diseases, emphasizing their complexity and the importance of vigilance.
STAT
MAY 31, 2025
This is the web version of STAT’s special newsletter from the annual meeting of the American Society of Oncology. For more updates on the latest in cancer news, sign up for our Cancer Briefing newsletter here. ASCO is usually sweltering, but it’s surprisingly chilly today. We’re back with a roundup of tragic paradoxes, a race for new breast cancer drugs, and all that jazz.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
STAT
MAY 31, 2025
CHICAGO — Amid ongoing uncertainty around funding for the National Institutes of Health, and what it could mean for U.S. innovation, a top Merck executive stressed that the agency is “an incredible super-highway for biomedicine,” and that it’s “a fragile thing.” The comments by Dean Li, Merck’s head of research and development, were made during a STAT event late Friday at the annual meeting of the American Society of Clinical Oncology, and ca
Expert insights. Personalized for you.
97 
Let's personalize your content